These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26850066)

  • 41. Immunoglobulin G (IgG) specific responses to recombinant Qβ displayed MSP3 and UB05 in plasma of asymptomatic
    Ngu L; Fotso HO; Nyebe I; Tchadji JC; Ambada G; Ndah A; Atechi B; Lissom A; Atabonkeng PE; Chukwuma G; Efezeuh V; Gyu PC; Esimone C; Nguedia JCA; Akum EA; Okeke M; Titanji VPK; Mbacham W; Bopda-Waffo A; Wapimewah GN
    Pan Afr Med J; 2024; 47():175. PubMed ID: 39036016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens.
    Fouda GG; Leke RF; Long C; Druilhe P; Zhou A; Taylor DW; Johnson AH
    Clin Vaccine Immunol; 2006 Dec; 13(12):1307-13. PubMed ID: 17035513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamics of anti-MSP3 and Pfs230 antibody responses and multiplicity of infection in asymptomatic children from southern Ghana.
    Amoah LE; Acquah FK; Ayanful-Torgby R; Oppong A; Abankwa J; Obboh EK; Singh SK; Theisen M
    Parasit Vectors; 2018 Jan; 11(1):13. PubMed ID: 29304870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of naturally acquired immunity to P. falciparum and approaches to identify merozoite antigen targets.
    Healer J; Chiu CY; Hansen DS
    Parasitology; 2018 Jun; 145(7):839-847. PubMed ID: 29144217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults.
    Anum D; Kusi KA; Ganeshan H; Hollingdale MR; Ofori MF; Koram KA; Gyan BA; Adu-Amankwah S; Badji E; Huang J; Belmonte M; Banania GJ; Kwofie TB; Villasante E; Dodoo D; Sedegah M
    Malar J; 2015 Jan; 14():20. PubMed ID: 25604473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children.
    Irani V; Ramsland PA; Guy AJ; Siba PM; Mueller I; Richards JS; Beeson JG
    Clin Infect Dis; 2015 Oct; 61(8):1244-52. PubMed ID: 26136391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.
    Polley SD; Mwangi T; Kocken CH; Thomas AW; Dutta S; Lanar DE; Remarque E; Ross A; Williams TN; Mwambingu G; Lowe B; Conway DJ; Marsh K
    Vaccine; 2004 Dec; 23(5):718-28. PubMed ID: 15542195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.
    Aguiar JC; Bolton J; Wanga J; Sacci JB; Iriko H; Mazeika JK; Han ET; Limbach K; Patterson NB; Sedegah M; Cruz AM; Tsuboi T; Hoffman SL; Carucci D; Hollingdale MR; Villasante ED; Richie TL
    PLoS One; 2015; 10(8):e0136109. PubMed ID: 26292257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential Patterns of IgG Subclass Responses to
    Dobaño C; Santano R; Vidal M; Jiménez A; Jairoce C; Ubillos I; Dosoo D; Aguilar R; Williams NA; Díez-Padrisa N; Ayestaran A; Valim C; Asante KP; Owusu-Agyei S; Lanar D; Chauhan V; Chitnis C; Dutta S; Angov E; Gamain B; Coppel RL; Beeson JG; Reiling L; Gaur D; Cavanagh D; Gyan B; Nhabomba AJ; Campo JJ; Moncunill G
    Front Immunol; 2019; 10():439. PubMed ID: 30930896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgG opsonization of merozoites: multiple immune mechanisms for malaria vaccine development.
    Hill DL; Schofield L; Wilson DW
    Int J Parasitol; 2017 Sep; 47(10-11):585-595. PubMed ID: 28668325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.
    Richards JS; Arumugam TU; Reiling L; Healer J; Hodder AN; Fowkes FJ; Cross N; Langer C; Takeo S; Uboldi AD; Thompson JK; Gilson PR; Coppel RL; Siba PM; King CL; Torii M; Chitnis CE; Narum DL; Mueller I; Crabb BS; Cowman AF; Tsuboi T; Beeson JG
    J Immunol; 2013 Jul; 191(2):795-809. PubMed ID: 23776179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced acquired antibodies to a chimeric Plasmodium falciparum antigen; UB05-09 is associated with protective immunity against malaria.
    Dinga JN; Gamua SD; Titanji VPK
    Parasite Immunol; 2017 Aug; 39(8):. PubMed ID: 28543553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.
    Miura K; Perera S; Brockley S; Zhou H; Aebig JA; Moretz SE; Miller LH; Doumbo OK; Sagara I; Dicko A; Ellis RD; Long CA
    PLoS One; 2011; 6(6):e20947. PubMed ID: 21695140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children.
    Dodoo D; Aikins A; Kusi KA; Lamptey H; Remarque E; Milligan P; Bosomprah S; Chilengi R; Osei YD; Akanmori BD; Theisen M
    Malar J; 2008 Jul; 7():142. PubMed ID: 18664257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progress in the development of recombinant and synthetic blood-stage malaria vaccines.
    Mahanty S; Saul A; Miller LH
    J Exp Biol; 2003 Nov; 206(Pt 21):3781-8. PubMed ID: 14506213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach.
    Taylor DW; Bobbili N; Kayatani A; Tassi Yunga S; Kidima W; Leke RFG
    Malar J; 2020 May; 19(1):171. PubMed ID: 32357882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identifying Immune Correlates of Protection Against Plasmodium falciparum Through a Novel Approach to Account for Heterogeneity in Malaria Exposure.
    Valmaseda A; Macete E; Nhabomba A; Guinovart C; Aide P; Bardají A; Bassat Q; Nhampossa T; Maculuve S; Casellas A; Quintó L; Sanz S; Jiménez A; Feng G; Langer C; Reiling L; Reddy KS; Pandey A; Chitnis CE; Chauhan VS; Aguilar R; Aponte JJ; Dobaño C; Beeson JG; Gaur D; Menéndez C; Alonso PL; Mayor A
    Clin Infect Dis; 2018 Feb; 66(4):586-593. PubMed ID: 29401272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood-stage malaria vaccines - recent progress and future challenges.
    Goodman AL; Draper SJ
    Ann Trop Med Parasitol; 2010 Apr; 104(3):189-211. PubMed ID: 20507694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential T-cell responses to a chimeric Plasmodium falciparum antigen; UB05-09, correlates with acquired immunity to malaria.
    Dinga JN; Njimoh DL; Kiawa B; Djikeng A; Nyasa RB; Nkuo-Akenji T; Pellé R; Titanji VP
    Parasite Immunol; 2016 May; 38(5):303-16. PubMed ID: 27012849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
    Sheehy SH; Duncan CJ; Elias SC; Choudhary P; Biswas S; Halstead FD; Collins KA; Edwards NJ; Douglas AD; Anagnostou NA; Ewer KJ; Havelock T; Mahungu T; Bliss CM; Miura K; Poulton ID; Lillie PJ; Antrobus RD; Berrie E; Moyle S; Gantlett K; Colloca S; Cortese R; Long CA; Sinden RE; Gilbert SC; Lawrie AM; Doherty T; Faust SN; Nicosia A; Hill AV; Draper SJ
    Mol Ther; 2012 Dec; 20(12):2355-68. PubMed ID: 23089736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.